Additional Resources

The original version of this bill amended the newborn screening law pertaining to storage of blood samples. All language was subsequently deleted pertaining to the newborn screening program. Bill Status: Died

The bill provides options to parents regarding blood samples collected for the purpose of newborn screening, including the right to authorize in writing that the blood sample and test results may be used for public health studies or research. Died. Bill Status: Died

Establishes a genetic marker testing pilot program. The program is intended to refine the understanding of disease onset and progression, treatment response, and health outcomes through more precise measurement of genetic factors that contribute to health and disease. Died. Bill Status: Died

A managed care organization that contracts with the health commissioner cannot discriminate or use any policy that has the effect of discriminating against people on the basis of genetic information. Died. Bill Status: Died

Establishes the MinnesotaCare program. A managed care organization that contracts with the Commissioner as part of the program may not discriminate or use any policy that has the effect of discriminating against people on the basis of genetic information. Died. Bill Status: Died

Establishes a pharmacogenetics task force. Died. Bill Status: Died

Modifies existing law pertaining to the use of genetic information by government entities and enacts a new consumer protection law regarding the use of genetic information. Died. Bill Status: Died

Businesses must conduct risk assessments of processing activities that involve sensitive consumer data, including genetic data. Died. Bill Status: Died

Establishes a pharmacogenetics task force. Died. Bill Status: Died

Businesses must conduct risk assessments of processing activities that involve sensitive consumer data, including genetic data. Died. Bill Status: Died